Target intelligence / Profile preview

Ribosomal protein S23 pseudogene 8 (RPS23P8)

Target
RPS23P8
Molecular classification
Other (Pseudogene)
01

Overview

Ribosomal protein S23 pseudogene 8 (RPS23P8) is a processed pseudogene in the human genome, corresponding to the ribosomal protein S23 gene but lacking coding capacity and functional protein product[2][8][11]. This pseudogene is one of many non-functional copies of ribosomal protein genes present in the human genome, arising from retrotransposition or duplication events[11]. RPS23P8 does not encode an active protein and has no established role in biological processes, disease association, or as a therapeutic target. It is included in genome annotation for completeness, but does not directly contribute to cellular or physiological function. Its main relevance is as a genomic feature, not as a drug target, biomarker, or pathway node. RPS23P8 is a pseudogene, meaning it is a defunct copy of a gene with no protein product and no demonstrated biological activity[2][8][11]. It is not considered a target for therapeutics, diagnostics, or research beyond its role in the study of genomic structure and evolution. The functional ribosomal protein is encoded by the RPS23 gene, which is distinct from this pseudogene and does have clear protein synthesis functions[4][7][10], but RPS23P8 itself is not implicated in these roles. There is no evidence of drug interactions, disease association, or therapeutic mechanisms linked to RPS23P8. In summary, RPS23P8 is a non-functional pseudogene, sometimes annotated for genomic research but not relevant as a molecular target or for pharmacological intervention.

Other names
RPS23_5_1783RPS23P8

Beyond the preview

Go deeper on Ribosomal protein S23 pseudogene 8 (RPS23P8).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein S23 pseudogene 8 (RPS23P8).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call